Anti tumor antibodies targeting CD47

doi:10.3760/cma.j.issn.1673422X.2013.11.005

Abstract

Abstract: CD47 is a pluripotent molecule which plays a key role in the process of tumor immune escape. Blocking CD47 signal pathway can activate the macrophages to phagocytose tumor cells, which becomes a promising way for tumor immunotherapy. Monoclonal antibodies targeting CD47 have been the new focus during recent years. Present researches are carried out successfully, however it still needs more work before the clinical application of monoclonal antibodies targeting CD47.

Key words: Neoplasms, Antibodys, Phagocytosis

WANG Yu-Shu, ZHOU Zhao-Ping, SU Qing-Ning. Anti tumor antibodies targeting CD47[J]. Journal of International Oncology, 2013, 40(11): 817-820.

References

［1］ Chao MP, Majeti R， Weissman IL. Programmed cell removal: a new obstacle in the road to developing cancer. Nat Rev Cancer, 2012,12(1): 58-67. ［2］ Sick E, Jeanne A, Schneider C, et al. CD47 update: a multifaceted actor in the tumor microenvironment of potential therapeutic interest. Br J Pharmacol, 2012,167(7):1415-1430. ［3］ Chao MP, Jaiswal S, WeissmanTsukamoto R, et al. Calreticulin is the dominant prophagocytic signal on multiple human cancers and is counterbalanced by CD47. Sci Transl Med, 2010,2(63)：63ra94. ［4］ Jaiswal S, Chao MP, Majeti R, et al. Macrophages as mediators of tumor immunosurveillance. Trends Immunol, 2010,31(6):212-219. ［5］ Chao MP, Weissman IL, Majeti R. The CD47SIRPα pathway in cancer immune evasion and potential therapeutic implications. Curr Opin Immunol, 2012,24(2):225-232. ［6］ Majeti R, Chao MP, Alizadeh AA, et al. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell, 2009,138(2):286-299. ［7］ Sagawa M, Shimizu T, Fukushima N, et al. A new disulfidelinked dimer of a singlechain antibody fragment against human CD47 induces apoptosis in lymphoid malignant cells via the hypoxia inducible factor1α pathway. Cancer Sci, 2011,102(6):1208-1215. ［8］ Chao MP, Alizadeh AA, Tang C, et al. Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia. Cancer Res, 2010,71(4):1374-1384. ［9］ Chao MP, Alizadeh AA, Tang C, et al. AntiCD47 antibody synergizes with rituximab to promote phagocytosis and eradicate nonHodgkin lymphoma. Cell, 2010,142(5):699-713. ［10］ Chao MP, Tang C, Pachynski RK, et al. Extranodal dissemination of nonHodgkin lymphoma requires CD47 and is inhibited by antiCD47 antibody therapy. Blood, 2011,118(18):4890-4901. ［11］ Kim D, Wang J, Willingham SB, et al. AntiCD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells. Leukemia, 2012,26(12):2538-2545. ［12］ Edris B, Weiskopf K, Weissman IL, et al. Flipping the script on macrophages in leiomyosarcoma. Oncoimmunology, 2012,1(7):1202-1204. ［13］ Edris B, Weiskopf K, Volkmer AK, et al. Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma. Proc Natl Acad Sci USA, 2012,109(17):6656-6661. ［14］ Sick E, Boukhari A, Deramaudt T, et al. Activation of CD47 receptors causes proliferation of human astrocytoma but not normal astrocytes via an aktdependent pathway. Glia, 2011,59(2):308-319. ［15］ Zhao XW, van Beek EM, Schornagel K, et al. CD47signal regulatory protein α (SIRPα) interactions form a barrier for antibodymediated tumor cell destruction. Proc Natl Acad Sci USA, 2011,108(45):18342-18347. ［16］ Willingham SB, Volkmer JP, Gentles AJ, et al. The CD47signal regulatory protein alpha (SIRPα) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci USA, 2012,109(17):6662-6667. ［17］ Hongrapipat J, Kopeckova P, Liu J, et al. Combination chemotherapy and photodynamic therapy with Fab′fragment targeted HPMA copolymer conjugates in human ovarian carcinoma cells. Mol Pharm, 2008,5(5):696-709. ［18］ Chan KS, Espinosa I, Chao M, et al. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumorinitiating cells. Proc Natl Acad Sci USA, 2009,106(33):14016-14021. ［19］ Kim MJ, Lee JC, Lee JJ, et al. Association of CD47 with natural killer cellmediated cytotoxicity of headandneck squamous cell carcinoma lines. Tumour Biol, 2008,29(1):28-34.